This content is machine translated Pulmonary hypertension PH and lung diseases Pulmonary hypertension (PH) describes a hemodynamic condition with a pathological increase in pressure in the pulmonary vascular circulation. Clinically, PH causes reduced performance, shortness of breath, angina and syncope. Comprehensive...… CME-Test
View Post 8 min This content is machine translated A syndrome between decompensation and chronification Worsening Heart Failure The deterioration of chronic heart failure – so-called worsening heart failure (WHF) – is no longer solely an acute event, but an expression of complex, often repetitive pathophysiological dynamics. Despite...…
View Post 8 min This content is machine translated Cardiogenic shock - 2025 update Between standardization, team processes and targeted cycle support Cardiogenic shock (CS) is and remains the most dramatic form of acute circulatory failure in cardiology. Despite decades of intensive research, hospital mortality has long remained in the range of...…
View Post 9 min This content is machine translated Catheter ablation for atrial fibrillation 2025 Pulsed field versus radio frequency – where do we stand? In the treatment of atrial fibrillation (AF), catheter ablation has developed from a specialized option to the mainstay of a modern rhythm strategy within a decade. In 2025, two developments...…
View Post 10 min This content is machine translated From the late residual valve to independent therapy Tricuspid interventions 2025 For a long time, the tricuspid valve was considered the “forgotten valve”. In 2025, there is nothing left of it. Within just a few years, an independent, evidence-based field has...…
View Post 11 min This content is machine translated Late-Breaking Science Antithrombotics & rhythm The ESC Congress 2025 in Madrid presented several studies in hot-line and late-breaking sessions that have a direct impact on the care of patients with atrial fibrillation, coronary heart disease,...…
View Post 6 min This content is machine translated AI-supported imaging and new biomarkers CHD diagnostics update Coronary heart disease remains one of the key challenges in cardiology. However, the way in which it is diagnosed is changing rapidly. Computed tomographic coronary angiography (CCTA), fractional flow reserve...…
View Post 5 min This content is machine translated Arterial hypertension: ESC guideline 2024 in focus New category “elevated blood pressure” – what are the therapeutic implications? According to the guideline of the European Society of Cardiology (ESC), which was updated last year, blood pressure values of 120-139/70-89 mmHg are considered “raised blood pressure”. Drug therapy is...…
View Post 6 min This content is machine translated DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline Stroke prevention for atrial fibrillation 2025 Atrial fibrillation is the most important treatable risk factor for ischemic strokes in 2025 – and at the same time an area where precision makes all the difference. The major...…
View Post 6 min This content is machine translated From early intervention to individualization The new guidelines at a glance At the ESC Congress 2025, several guidelines and a consensus document were published or revised, which together will have a noticeable impact on everyday cardiology: a focused update on lipid...…
View Post 6 min This content is machine translated Chronic and acute coronary syndrome Proactive and evidence-based decision-making The clinical management of chronic coronary syndrome requires precise risk stratification by means of symptom analysis, imaging and invasive diagnostics. An important aspect is the assessment of ischemia in non-obstructive...…
